Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer

References

Page 1

	Year	Citations
A new look at the statistical model identification Hirotugu Akaike IEEE Transactions on Automatic Control Parameter EstimationEngineeringParameter IdentificationData ScienceFinancial Time Series Analysis	1974	49.6K
Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach Fred S. Guthery, Kenneth P. Burnham, David Anderson Journal of Wildlife Management EngineeringLikelihood TheoryBiostatisticsStatistical InferenceModel Comparison	2003	42.1K
Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs C. Thomas Gualtieri, Leigh Johnson Archives of Clinical Neuropsychology	2006	851
Filgrastim (r-metHuG-CSF): the first 10 years Karl Welte, Janice Gabrilove, MH Bronchud, Blood	1996	608
Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils Amy-Jo Casbon, Damien Reynaud, Chanhyuk Park, Proceedings of the National Academy of Sciences	2015	457
Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. G-J Zhang, I Adachi PubMed Breast OncologyImmunologyPathologyPleural EffusionImmunotherapy	1999	309
Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study Arti Hurria, Carol L. Rosen, Clifford A. Hudis, Journal of the American Geriatrics Society	2006	262
Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Leszek Kozłowski, I Zakrzewska, Piotr Tokajuk, PubMed	2003	251
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study Yin Ting Cheung, Terence Ng, M. Shwe, Annals of Oncology	2015	235
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası, Journal of Neuroimmunology Alzheimer's DiseaseMedicineDementiaImmunologyVascular Dementia	2015	227

Page 1